|
Twitter
|
Facebook
|
Google+
|
VKontakte
|
LinkedIn
|
Viadeo
|
English
|
Français
|
Español
|
العربية
|
 
International Journal of Innovation and Applied Studies
ISSN: 2028-9324     CODEN: IJIABO     OCLC Number: 828807274     ZDB-ID: 2703985-7
 
 
Friday 29 March 2024

About IJIAS

News

Submission

Downloads

Archives

Custom Search

Contact

  • Contact us
  • Newsletter:

Connect with IJIAS

  Now IJIAS is indexed in EBSCO, ResearchGate, ProQuest, Chemical Abstracts Service, Index Copernicus, IET Inspec Direct, Ulrichs Web, Google Scholar, CAS Abstracts, J-Gate, UDL Library, CiteSeerX, WorldCat, Scirus, Research Bible and getCited, etc.  
 
 
 

In vitro activity of imipenem combination with colistin or rifampicin against clinical isolates of Acinetobacter baumannii and his antimicrobial susceptibility profil


Volume 8, Issue 3, September 2014, Pages 1252–1257

 In vitro activity of imipenem combination with colistin or rifampicin against clinical isolates of Acinetobacter baumannii and his antimicrobial susceptibility profil

Imane ES-SAID1, Hicham ELFAZAZI2, and Mimoun Zouhdi3

1 Department of Microbiology, Faculty of Medicine and Pharmacy, Mohammed V-Souissi, Rabat, Morocco
2 Department of Gynecology Obstetrics, Mohammed V Military Hospital, Rabat, Morocco
3 Microbiology Laboratory, Ibn Sina Hospital, Rabat, Morocco

Original language: English

Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract


Background: Acinetobacter baumannii (A. baumannii) is one of the most important nosocomial pathogens, Increasing resistance coupled with the fact that few novel antibiotics are currently available or in the pipeline, leaves patients and physicians with a very limited armamentarium against these pathogens. Combination therapies are considered as effective options to overcome this matter. Materials and methods: Fifty A. baumannii isolates were collected from clinical specimens, from patients in ICU at Ibn Sina Hospital in Rabat, Morocco during the January 2011

Author Keywords: Imipenem, colistin, rifampicin, combination, Acinetobacter baumannii.


How to Cite this Article


Imane ES-SAID, Hicham ELFAZAZI, and Mimoun Zouhdi, “In vitro activity of imipenem combination with colistin or rifampicin against clinical isolates of Acinetobacter baumannii and his antimicrobial susceptibility profil,” International Journal of Innovation and Applied Studies, vol. 8, no. 3, pp. 1252–1257, September 2014.